Step in with Caution
Intro
A major transformation started coming around in 2019 in the form of the fourth industrial revolution, Industry 4.0. It has gradually gained momentum as a blend of advanced analytics, Big Data, Robotics & Automation, Artificial Intelligence, Internet of Things (IoT) and Process Digitisation across the healthcare business value chain. Pharma, medical device and biotechnology innovators are harnessing digital technology and the power of big data and advanced analytics to deliver a more cost effective approach to healthcare in 2020. However, there lies a word of caution for the pharma industry particularly with respect to the aftermath of US-China trade tensions and the upcoming US elections in 2020. This requires the industry to take appropriate and careful steps to ensure the targeted growth.
The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc
